2004
DOI: 10.1016/j.jinorgbio.2004.09.014
|View full text |Cite
|
Sign up to set email alerts
|

A novel cytotoxic ternary copper(II) complex of 1,10-phenanthroline and l-threonine with DNA nuclease activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
68
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 229 publications
(76 citation statements)
references
References 40 publications
8
68
0
Order By: Relevance
“…The complexes are in good agreement with the previously reported square pyramidal geometry of the complexes [20][21][22] .…”
Section: Electronic Absorption Spectrasupporting
confidence: 91%
See 1 more Smart Citation
“…The complexes are in good agreement with the previously reported square pyramidal geometry of the complexes [20][21][22] .…”
Section: Electronic Absorption Spectrasupporting
confidence: 91%
“…Very recently, mixed ligand copper(II) complexes have been found to exhibit prominent anticancer activity by inducing apoptosis and, interestingly, they are found to strongly bind and cleave DNA [35][36][37] . In general, redoxactive agents that damage DNA in vitro are thought to exhibit apoptotic activities in live cells by inducing oxidative stress and/or DNA damage [38] .…”
Section: Anticancer Activitymentioning
confidence: 99%
“…Cu(II) complexes containing heterocyclic bases have been extensively explored in virtue of their strong interactions with DNA and cytotoxic activity [7][8][9]. They can act as chemical nucleases [10,11] and their cytotoxicity has been proposed to be caused by their ability to bind and cleave DNA that leads to cell cycle arrest and apoptosis or generation of reactive oxygen species (ROS) that in turn leads to cell death [12]. Literature has shown that Cu(II)-based complexes exhibit antineoplastic potency towards human ovarian carcinoma (CH1), murine leukemia (L1210), and various cervicouterine carcinomas which is comparable to or even higher than that of cisplatin [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Recently there are several reports of copper(II) complexes showing efficient chemical nuclease activity [12][13][14][15]. Recent reports have also shown that amino acid/peptide based copper(II) complexes show efficient DNA cleavage activity by oxidative and hydrolytic pathways [15][16][17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%